Placebo Controlled Proof of Concept Study to Investigate ANB020 Activity in Adult Patients With Severe Eosinophilic Asthma

Trial Profile

Placebo Controlled Proof of Concept Study to Investigate ANB020 Activity in Adult Patients With Severe Eosinophilic Asthma

Recruiting
Phase of Trial: Phase II

Latest Information Update: 18 May 2018

At a glance

  • Drugs ANB 020 (Primary)
  • Indications Asthma
  • Focus Adverse reactions; Proof of concept; Therapeutic Use
  • Sponsors AnaptysBio
  • Most Recent Events

    • 26 Mar 2018 According to an AnaptysBio media release, top-line data are anticipated in the third quarter of 2018.
    • 07 Nov 2017 According to an AnaptysBio media release, top-line data from this trial are expected in the second quarter of 2018.
    • 10 Oct 2017 Status changed from planning to recruiting according to an AnaptysBio media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top